Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Pharmacotherapy - 44(2024), 2 vom: 16. Feb., Seite 208-209 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hong, Lisa T [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 19.02.2024 Date Revised 19.02.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/phar.2907 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368527158 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368527158 | ||
003 | DE-627 | ||
005 | 20240219232114.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240216s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/phar.2907 |2 doi | |
028 | 5 | 2 | |a pubmed24n1299.xml |
035 | |a (DE-627)NLM368527158 | ||
035 | |a (NLM)38362632 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hong, Lisa T |e verfasserin |4 aut | |
245 | 1 | 0 | |a Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists" |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.02.2024 | ||
500 | |a Date Revised 19.02.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a beta-Lactams |2 NLM | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
700 | 1 | |a Downes, Kevin J |e verfasserin |4 aut | |
700 | 1 | |a FakhriRavari, Alireza |e verfasserin |4 aut | |
700 | 1 | |a Abdul-Mutakabbir, Jacinda C |e verfasserin |4 aut | |
700 | 1 | |a Kuti, Joseph L |e verfasserin |4 aut | |
700 | 1 | |a Jorgensen, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Young, David C |e verfasserin |4 aut | |
700 | 1 | |a Alshaer, Mohammad H |e verfasserin |4 aut | |
700 | 1 | |a Bassetti, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Bonomo, Robert A |e verfasserin |4 aut | |
700 | 1 | |a Gilchrist, Mark |e verfasserin |4 aut | |
700 | 1 | |a Jang, Soo Min |e verfasserin |4 aut | |
700 | 1 | |a Lodise, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Roberts, Jason A |e verfasserin |4 aut | |
700 | 1 | |a Tängdén, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Zuppa, Athena |e verfasserin |4 aut | |
700 | 1 | |a Scheetz, Marc H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacotherapy |d 1983 |g 44(2024), 2 vom: 16. Feb., Seite 208-209 |w (DE-627)NLM012960926 |x 1875-9114 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2024 |g number:2 |g day:16 |g month:02 |g pages:208-209 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/phar.2907 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2024 |e 2 |b 16 |c 02 |h 208-209 |